Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07029581

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Conditions: Lewy Body Dementia Psychosis

Sex: All
Ages: 55 Years – 84 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 180
Sponsor: ACADIA Pharmaceuticals Inc.

Location: ATP Clinical Research Inc. Irvine California

Summary

Multicenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.

Eligibility Criteria

Inclusion Criteria: * Male or female ≥55 years to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07029581). StuddyBuddy aggregates publicly available trial information.